Asahi Kasei to buy Veloxis Pharmaceuticals through $1.3 billion tender offer
MLex Summary: Japan’s Asahi Kasei, a chemical-centered manufacturer, plans to buy US pharmaceutical company Veloxis Pharmaceuticals through a tender offer for Denmark-based Veloxis Pharmaceuticals A/S, which owns 100 percent of the...To view the full article, register now.
Already a subscriber? Click here to view full article